/VTAK
VTAK Stock - Catheter Precision, Inc.
Healthcare|Medical - DevicesAMEX
$1.98-10.81%
$0.24 (-10.81%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.18
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VTAK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.96 – $2.00
TARGET (TP)$2.28
STOP LOSS$1.82
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.19
52W High$15.77
52W Low$1.49
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $420,000 | $442,000 | $14,000 | $22,000 | $259,000 |
| Gross Profit | $378,000 | $412,000 | $-147,000 | $-1,538,000 | $-1,913,000 |
| Gross Margin | 90.0% | 93.2% | -1050.0% | -6990.9% | -738.6% |
| Operating Income | $-11,243,000 | $-78,119,000 | $-26,961,000 | $-29,266,000 | $-35,401,000 |
| Net Income | $-16,643,000 | $-70,572,000 | $-26,865,000 | $-25,070,000 | $-36,045,000 |
| Net Margin | -3962.6% | -15966.5% | -191892.9% | -113954.5% | -13917.0% |
| EPS | $-6.68 | $-12.99 | $-25.98 | $-248.22 | $-1060.77 |
Company Overview
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VTAKBeat Rate
64%
Last 14 quarters
Avg Surprise
+698.2%
EPS vs Estimate
Beats / Misses
9/5
Last 12 quarters
Latest EPS
$-1.70
Q4 2025
EPS Surprise History
Q1 24
+65.4%
$-0.09vs$-0.26
Q2 24
+14.3%
$-0.36vs$-0.42
Q3 24
-111.8%
$-5.57vs$-2.63
Q4 24
-11.7%
$-2.01vs$-1.80
Q1 25
-251.5%
$-0.70vs$-0.20
Q2 25
-80.0%
$-0.36vs$-0.20
Q3 25
+78.9%
$-7.22vs$-34.20
Q4 25
+93.6%
$-1.70vs$-26.60
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q1 2026 | Mar 19, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $-26.60 | $-1.70 | +93.6% | ✓ BEAT |
Q3 2025 | Aug 11, 2025 | $-34.20 | $-7.22 | +78.9% | ✓ BEAT |
Q2 2025 | May 14, 2025 | $-0.20 | $-0.36 | -80.0% | ✗ MISS |
Q1 2025 | Mar 31, 2025 | $-0.20 | $-0.70 | -251.5% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $-1.80 | $-2.01 | -11.7% | ✗ MISS |
Q3 2024 | Aug 14, 2024 | $-2.63 | $-5.57 | -111.8% | ✗ MISS |
Q2 2024 | May 6, 2024 | $-0.42 | $-0.36 | +14.3% | ✓ BEAT |
Q1 2024 | Mar 28, 2024 | $-0.26 | $-0.09 | +65.4% | ✓ BEAT |
Q4 2023 | Dec 15, 2023 | $-0.23 | $6.10 | +2752.2% | ✓ BEAT |
Q3 2023 | Sep 28, 2023 | $0.30 | $-0.29 | -197.9% | ✗ MISS |
Q2 2023 | Jun 2, 2023 | $0.34 | $24.65 | +7150.0% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | $-80.00 | $-3.78 | +95.3% | ✓ BEAT |
Q3 2022 | Sep 30, 2022 | $-80.00 | $-4.36 | +94.5% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | — | $-13.13 | — | — |
Q1 2022 | Mar 31, 2022 | $-80.00 | $-13.71 | +82.9% | ✓ BEAT |
Q4 2021 | Dec 31, 2021 | — | $-61.46 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-33.58 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-64.18 | — | — |
Latest News
Catheter Precision Launches LockeT Suture Retention Device In Switzerland
📈 PositiveBenzinga•Dec 1, 2025, 01:02 PM
Catheter Precision, Inc. Common Stock Q3 EPS $(1.70) Misses $(0.11) Estimate, Sales $226.000K Miss $1.700M Estimate
📉 NegativeBenzinga•Nov 13, 2025, 09:40 PM
Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study
📈 PositiveBenzinga•Aug 21, 2025, 12:21 PM
Catheter Precision shares are trading higher after the company announced UK registration and approval for LockeT.
📈 PositiveBenzinga•Aug 18, 2025, 02:55 PM
Catheter Precision Announces Registration And Approval In UK For LockeT
📈 PositiveBenzinga•Aug 18, 2025, 12:06 PM
Frequently Asked Questions about VTAK
What is VTAK's current stock price?
Catheter Precision, Inc. (VTAK) is currently trading at $1.98 per share. The stock has moved -10.81% today.
What is the analyst price target for VTAK?
No analyst price targets are currently available for this stock.
What sector is Catheter Precision, Inc. in?
Catheter Precision, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the AMEX exchange.
What is VTAK's market cap?
Catheter Precision, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does VTAK pay dividends?
No, Catheter Precision, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBBLG
Bone Biologics Corporation
$1.83
Mkt Cap: $0.0B
CERO
CERo Therapeutics Holdings, Inc.
$0.10
Mkt Cap: $0.0B
ELAB
PMGC Holdings Inc.
$2.26
Mkt Cap: $0.0B
GLMD
Galmed Pharmaceuticals Ltd.
$0.85
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
ISPC
iSpecimen Inc.
$0.37
Mkt Cap: $0.0B
NIVF
NewGenIvf Group Limited
$0.90
Mkt Cap: $0.0B
TIVC
Tivic Health Systems, Inc.
$1.74
Mkt Cap: $0.0B
UPC
Universe Pharmaceuticals Inc.
$3.73
Mkt Cap: $0.0B
WOK
WORK Medical Technology Group Ltd.
$0.05
Mkt Cap: $0.0B
Explore stocks similar to VTAK for comparison